Filters:

UEG Online Course

not accredited

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Metabolic Dysfunction-Associated Steatotic Liver Disease

Quentin Anstee, Stuart McPherson, Kate Hallsworth, Laura Haigh

Summary

AI Generated

An online course provides a comprehensive update on all aspects of nonalcoholic fatty liver disease, covering epidemiology, biomarkers, care pathways, lifestyle interventions, and pharmacotherapy.

The course addresses NAFLD, a highly prevalent but largely asymptomatic disease that poses a major challenge to healthcare systems worldwide, with considerable variation in disease severity and outcome.
Content covers epidemiology and natural history of NAFLD, biomarkers, patient identification and care pathways, dietary and lifestyle interventions, and pharmacotherapy.
The course includes detailed PPT slides and video presentations filmed in May 2022, with an estimated completion time of 120 minutes including final assessment.
The target audience includes gastroenterologists and hepatologists in training, liver pathologists, endocrinologists, diabetologists, primary care physicians, nurses, allied health professionals, basic scientists in translational biomedicine, and medical students.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent but largely asymptomatic disease that poses a major challenge to healthcare systems worldwide. Disease severity and outcome vary considerably and those at greatest risk of progression from steatosis and steatohepatitis to cirrhosis and hepatocellular carcinoma need to be identified.

This online course, from the multidisciplinary team of Quentin M. Anstee, Stuart McPherson, Kate Hallsworth and Laura Haigh, provides a comprehensive update on all aspects of NAFLD. After introducing the epidemiology and natural history of NAFLD, the course turns its attention to biomarkers, patient identification and care pathways, dietary and lifestyle interventions, and pharmacotherapy.

The course includes detailed PPT slides and bespoke video presentations, which were filmed in May 2022. The estimated time needed to complete the course, including the final assessment, is 120 minutes.

Target audience

This course is designed for gastroenterologists and/or hepatologists in training, liver pathologists, endocrinologists/diabetologists, primary care physicians, nurses, allied health professionals, basic scientists working in translational biomedicine, and medical students.

Event

Metabolic Dysfunction-Associated Steatotic Liver Disease

Topics

Hepatobiliary

Accreditation status

not accredited

Duration

2 hours

Published

2022

More Like This:

Gastroenterologist's guide to stem cells

Stuart McDonald

Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0.

Alberto Zanetto

Barrett Oesophagus - pathophysiology, diagnosis, surveillance and treatment

Eva Verheij

Acute pancreatitis

Markus M. Lerch

How to develop guidelines - Part 1

Ana Dugic

GORD Pathophysiology - Part 2

Ahsen Ustaoglu

UEG Online Course

accredited

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.